# Conditional Antibody Design as 3D Equivariant Graph Translation

arXiv: https://arxiv.org/abs/2208.06073 · HTML: https://mlsanity.com/paper/2208.06073/

## Key facts

- Cited by 75 papers in the map (data through 14 Oct 2026).
- Builds on 14 of its 52 references that are in the map.
- First posted on arXiv 12 Aug 2022.

## Builds on (most cited first, 14 of 14)

- [Graph Attention Networks](https://mlsanity.com/paper/1710.10903/) (2017)
- [E(n) Equivariant Graph Neural Networks](https://mlsanity.com/paper/2102.09844/) (2021)
- [Directional Message Passing for Molecular Graphs](https://mlsanity.com/paper/2003.03123/) (2020)
- [Symmetry-adapted generation of 3d point sets for the targeted discovery of molecules](https://mlsanity.com/paper/1906.00957/) (2019)
- [Spherical Message Passing for 3D Graph Networks](https://mlsanity.com/paper/2102.05013/) (2021)
- [Frame Averaging for Invariant and Equivariant Network Design](https://mlsanity.com/paper/2110.03336/) (2021)
- [Iterative Refinement Graph Neural Network for Antibody Sequence-Structure Co-design](https://mlsanity.com/paper/2110.04624/) (2021)
- [Independent SE(3)-Equivariant Models for End-to-End Rigid Protein Docking](https://mlsanity.com/paper/2111.07786/) (2021)
- [Equivariant Graph Mechanics Networks with Constraints](https://mlsanity.com/paper/2203.06442/) (2022)
- [Geometrically Equivariant Graph Neural Networks: A Survey](https://mlsanity.com/paper/2202.07230/) (2022)
- [Deciphering antibody affinity maturation with language models and weakly supervised learning](https://mlsanity.com/paper/2112.07782/) (2021)
- [Fold2Seq: A Joint Sequence(1D)-Fold(3D) Embedding-based Generative Model for Protein Design](https://mlsanity.com/paper/2106.13058/) (2021)
- [Improving Molecular Design by Stochastic Iterative Target Augmentation](https://mlsanity.com/paper/2002.04720/) (2020)
- [AntBO: Towards Real-World Automated Antibody Design with Combinatorial Bayesian Optimisation](https://mlsanity.com/paper/2201.12570/) (2022)

## Built on by (most cited first, 30 of 75)

- [Structure-informed Language Models Are Protein Designers](https://mlsanity.com/paper/2302.01649/) (2023)
- [DPLM-2: A Multimodal Diffusion Protein Language Model](https://mlsanity.com/paper/2410.13782/) (2024)
- [End-to-End Full-Atom Antibody Design](https://mlsanity.com/paper/2302.00203/) (2023)
- [Protein Discovery with Discrete Walk-Jump Sampling](https://mlsanity.com/paper/2306.12360/) (2023)
- [AbDiffuser: Full-Atom Generation of in vitro Functioning Antibodies](https://mlsanity.com/paper/2308.05027/) (2023)
- [Full-Atom Peptide Design based on Multi-modal Flow Matching](https://mlsanity.com/paper/2406.00735/) (2024)
- [Protein Sequence and Structure Co-Design with Equivariant Translation](https://mlsanity.com/paper/2210.08761/) (2022)
- [Antigen-Specific Antibody Design via Direct Energy-based Preference Optimization](https://mlsanity.com/paper/2403.16576/) (2024)
- [A Survey of Generative AI for de novo Drug Design: New Frontiers in Molecule and Protein Generation](https://mlsanity.com/paper/2402.08703/) (2024)
- [A Survey of Geometric Graph Neural Networks: Data Structures, Models and Applications](https://mlsanity.com/paper/2403.00485/) (2024)
- [ProteinBench: A Holistic Evaluation of Protein Foundation Models](https://mlsanity.com/paper/2409.06744/) (2024)
- [FoldToken: Learning Protein Language via Vector Quantization and Beyond](https://mlsanity.com/paper/2403.09673/) (2024)
- [ProteinGPT: Multimodal LLM for Protein Property Prediction and Structure Understanding](https://mlsanity.com/paper/2408.11363/) (2024)
- [Reprogramming Pretrained Language Models for Antibody Sequence Infilling](https://mlsanity.com/paper/2210.07144/) (2022)
- [Generalist Equivariant Transformer Towards 3D Molecular Interaction Learning](https://mlsanity.com/paper/2306.01474/) (2023)
- [CBGBench: Fill in the Blank of Protein-Molecule Complex Binding Graph](https://mlsanity.com/paper/2406.10840/) (2024)
- [ProtChatGPT: Towards Understanding Proteins with Large Language Models](https://mlsanity.com/paper/2402.09649/) (2024)
- [Are High-Degree Representations Really Unnecessary in Equivariant Graph Neural Networks?](https://mlsanity.com/paper/2410.11443/) (2024)
- [FABind: Fast and Accurate Protein-Ligand Binding](https://mlsanity.com/paper/2310.06763/) (2023)
- [Topological Neural Networks go Persistent, Equivariant, and Continuous](https://mlsanity.com/paper/2406.03164/) (2024)
- [Re-Dock: Towards Flexible and Realistic Molecular Docking with Diffusion Bridge](https://mlsanity.com/paper/2402.11459/) (2024)
- [AbODE: Ab Initio Antibody Design using Conjoined ODEs](https://mlsanity.com/paper/2306.01005/) (2023)
- [Protein 3D Graph Structure Learning for Robust Structure-based Protein Property Prediction](https://mlsanity.com/paper/2310.11466/) (2023)
- [A Hierarchical Training Paradigm for Antibody Structure-sequence Co-design](https://mlsanity.com/paper/2311.16126/) (2023)
- [UniMoMo: Unified Generative Modeling of 3D Molecules for De Novo Binder Design](https://mlsanity.com/paper/2503.19300/) (2025)
- [Learning to Predict Mutation Effects of Protein-Protein Interactions by Microenvironment-aware Hierarchical Prompt Learning](https://mlsanity.com/paper/2405.10348/) (2024)
- [Large Language-Geometry Model: When LLM meets Equivariance](https://mlsanity.com/paper/2502.11149/) (2025)
- [dyAb: Flow Matching for Flexible Antibody Design with AlphaFold-driven Pre-binding Antigen](https://mlsanity.com/paper/2503.01910/) (2025)
- [An All-Atom Generative Model for Designing Protein Complexes](https://mlsanity.com/paper/2504.13075/) (2025)
- [Retrieval Augmented Diffusion Model for Structure-informed Antibody Design and Optimization](https://mlsanity.com/paper/2410.15040/) (2024)

## Abstract (arXiv)

Antibody design is valuable for therapeutic usage and biological research. Existing deep-learning-based methods encounter several key issues: 1) incomplete context for Complementarity-Determining Regions (CDRs) generation; 2) incapability of capturing the entire 3D geometry of the input structure; 3) inefficient prediction of the CDR sequences in an autoregressive manner. In this paper, we propose Multi-channel Equivariant Attention Network (MEAN) to co-design 1D sequences and 3D structures of CDRs. To be specific, MEAN formulates antibody design as a conditional graph translation problem by importing extra components including the target antigen and the light chain of the antibody. Then, MEAN resorts to E(3)-equivariant message passing along with a proposed attention mechanism to better capture the geometrical correlation between different components. Finally, it outputs both the 1D sequences and 3D structure via a multi-round progressive full-shot scheme, which enjoys more efficiency and precision against previous autoregressive approaches. Our method significantly surpasses state-of-the-art models in sequence and structure modeling, antigen-binding CDR design, and binding affinity optimization. Specifically, the relative improvement to baselines is about 23% in antigen-binding CDR design and 34% for affinity optimization.
